Tofa For UC

AddtoAny
Share:

WATCH THIS PAGE

Subscribe to be notified of changes or updates to this page.

8 + 3 =
Solve this simple math problem and enter the result. E.g. for 1+3, enter 4.

The purpose of this research study is to help us understand how well tofacitinib works as a treatment for ulcerative colitis or indeterminate colitis in pediatric patients. We are looking to enroll, males or females ages 6 to 21 years old with a diagnosis of ulcerative colitis or indeterminate colitis who have started tofacitinib therapy prescribed by their primary gastroenterologist within the past 2 weeks or will be starting tofafacitinib within 1 month.

Eligibility & Criteria

IRB #:
20-017316
Official Title:
An Observational Study of the Natural History of Tofacitinib for Clinical Treatment of Severe Pediatric Ulcerative Colitis and Indeterminate Colitis
Study Phase:
Not Applicable
Eligible Age Range:
6 - 21 Years
Gender:
All
Study Categories:
Leader
Ronen Stein

Ronen Stein, MD